Hormonal migraine treatment
Start your consultation ›Hormonal migraine treatment depends on the underlying cause, severity and stage of life. Options may include migraine-specific medicines such as triptans, preventative therapies, newer CGRP-targeted treatments and hormone optimisation through HRT.
For many women, the most effective approach combines migraine treatment with management of hormonal fluctuations, sleep, stress and lifestyle factors. This guide walks through each option available in the UK.
For most women, first-line treatment involves migraine-specific medicines called triptans, designed to stop a migraine attack once it begins. They work best taken early in the attack.
During a migraine, certain nerves and blood vessels become activated, causing pain and inflammation. Triptans are generally more effective than standard painkillers for moderate to severe attacks. They help by:
One of the most widely prescribed migraine medicines in the UK and a common first-line choice. It works on serotonin receptors involved in migraine pathways, with many women feeling relief within 1–2 hours.
Another commonly prescribed triptan that often works faster than sumatriptan. Many women find it particularly useful when nausea accompanies attacks, and it is effective for moderate to severe migraine.
Available as tablets and a nasal spray, and may help women whose migraines do not respond fully to other triptans. The nasal spray can suit those experiencing vomiting during attacks.
Preventative treatments are taken regularly to reduce the frequency and severity of attacks. They may be recommended if migraines are frequent, disabling, or not controlled by acute treatment alone.
The goal is fewer migraine days and improved quality of life.
One of the most commonly prescribed migraine-prevention medicines in the UK. It reduces migraine frequency by affecting the nervous system and blood-vessel responses involved in attacks, and may also help anxiety symptoms.
Can significantly reduce migraine frequency in some women by acting on brain-signalling pathways involved in migraine activity.
Recent advances have transformed migraine treatment. New therapies target CGRP (Calcitonin Gene-Related Peptide), a key biological driver of attacks, and are often considered when traditional therapies have not worked well.
Blocks CGRP activity. Many with chronic migraine see fewer migraine days, reduced severity and better quality of life.
A CGRP antibody designed to prevent attacks before they start. Effective for chronic and episodic migraine and well tolerated by many.
Targets CGRP and may significantly reduce migraine frequency, improving daily functioning as a long-term option.
Given by infusion, with rapid onset and long-lasting preventative effect — useful for frequent attacks.
Unlike triptans, it directly targets the CGRP pathway. Can be used to treat an attack and, in some cases, to prevent them — an alternative for women unable to use triptans.
An oral preventative that blocks CGRP activity. A daily tablet option that reduces migraine frequency for many women with frequent attacks — a major advance in prevention.
For women whose migraines are linked to hormonal fluctuations, addressing the hormonal trigger can be just as important as treating the migraine itself.
Many hormonal migraines are triggered by falling or fluctuating oestrogen. Transdermal oestrogen provides more stable delivery through the skin, which many menopause specialists prefer for women with migraine.
Some women are sensitive to certain forms of progesterone. The type, dose and timing can influence headaches, migraine frequency, mood and sleep quality.
For some women, switching to micronised progesterone or adjusting the regimen improves symptoms significantly. The goal is the most stable hormonal environment possible while managing menopause symptoms.
Hormonal migraines are often complex, and many women have been told they simply need to “put up with them.” We take a more personalised approach, addressing both symptoms and root causes.
We assess the full picture:
Your plan may include:
Hormonal migraines change over time. We help you:
What is the best treatment for hormonal migraines?
The best treatment depends on the cause of your migraines. Many women benefit from a combination of migraine medication, such as triptans or preventatives, and hormonal management through HRT.
Can HRT help hormonal migraines?
Yes. Stable hormone delivery through transdermal HRT such as patches, gel or spray may reduce migraine frequency in some women by smoothing out the oestrogen fluctuations that trigger attacks.
What is the newest migraine treatment available in the UK?
New CGRP-targeted treatments such as erenumab, fremanezumab, galcanezumab, eptinezumab, rimegepant and atogepant have significantly expanded treatment options and target the biological mechanisms behind migraine.
Are hormonal migraines treatable?
Yes. Effective treatments are available, and many women achieve significant improvement with a personalised treatment approach that addresses both the migraine and its hormonal triggers.
When should I seek help for hormonal migraines?
If migraines are affecting your work, relationships, sleep or quality of life, it is worth seeking professional assessment and support. Effective treatment is available.
Hormonal migraines are common, but they should not be accepted as an inevitable part of life. Whether yours are linked to periods, perimenopause, menopause or HRT, effective treatment options are available.
From triptans and preventatives to newer CGRP-targeted therapies and hormone optimisation, there are more solutions than ever before. The key is understanding your triggers, identifying the role hormones play, and creating a personalised plan that helps you feel like yourself.